Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 94 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $281,000 | -26.6% | 23,646 | 0.0% | 0.13% | -13.1% |
| Q4 2021 | $383,000 | +6.7% | 23,646 | +88.0% | 0.14% | -8.2% |
| Q3 2021 | $359,000 | -22.6% | 12,578 | -8.4% | 0.16% | -17.3% |
| Q2 2021 | $464,000 | +27.8% | 13,728 | +14.5% | 0.19% | +24.8% |
| Q1 2021 | $363,000 | -37.1% | 11,993 | +2.8% | 0.15% | -36.0% |
| Q4 2020 | $577,000 | +105.3% | 11,662 | +59.6% | 0.24% | +62.6% |
| Q3 2020 | $281,000 | -21.7% | 7,309 | -12.0% | 0.15% | -13.5% |
| Q2 2020 | $359,000 | +21.3% | 8,309 | -26.7% | 0.17% | +39.3% |
| Q1 2020 | $296,000 | -27.1% | 11,332 | -12.9% | 0.12% | +84.8% |
| Q4 2019 | $406,000 | – | 13,003 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $1,041,909 | 4.24% |
| Sofinnova Investments, Inc. | 2,194,278 | $11,958,815 | 0.75% |
| DENALI ADVISORS LLC | 85,900 | $468,155 | 0.16% |
| Polar Capital Holdings Plc | 2,103,298 | $11,462,974 | 0.08% |
| Soleus Capital Management, L.P. | 157,182 | $856,642 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 137,299 | $748 | 0.06% |
| Caligan Partners LP | 23,321 | $127,099 | 0.06% |
| Corton Capital Inc. | 12,244 | $66,730 | 0.03% |
| RICE HALL JAMES & ASSOCIATES, LLC | 91,249 | $497,307 | 0.03% |
| CIM INVESTMENT MANAGEMENT INC | 15,313 | $83,456 | 0.03% |